Skip links
Companies
› United States › SORRENTO THERAPEUTICS, INC.
SORRENTO THERAPEUTICS, INC. logo

SORRENTO THERAPEUTICS, INC.

Active

in

Registration No.
3263030
Incorporation Date
2009-12-07
Company Type
Not disclosed
Address
SAN DIEGO, United States
Website
www.sorrentotherapeutics.com/
Source: California Secretary of State — bizfile Online

SORRENTO THERAPEUTICS, INC. is a registered legal entity registered in United States under 3263030, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 7 December 2009 and lists its registered address as SAN DIEGO, United States. 3 shareholders are on record for SORRENTO THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 4 October 2026.

Data Provenance
This record is sourced directly from official government registries, including California Secretary of State — bizfile Online.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

3

Three shareholders are currently on record for SORRENTO THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is BlackRock Funds V-BlackRock High Yield Portfolio, holding 97.1% — a majority holding — followed by BlackRock Funds V-BlackRock Income Fund at 1.5%; the remaining 1 shareholder shown holds smaller stakes.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
BlackRock Funds V-BlackRock High Yield Portfolio 97.1% California Secretary of State — bizfile Online
BlackRock Funds V-BlackRock Income Fund 1.5% California Secretary of State — bizfile Online
Financial Gravity Companies, Inc. 0% California Secretary of State — bizfile Online

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Chairman, President & Ceo of SORRENTO THERAPEUTICS, INC. currently on record is Henry H. Ji Ph.d.; five officers are currently on record for SORRENTO THERAPEUTICS, INC., filed with California Secretary of State — bizfile Online.

The register reports 6 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at SORRENTO THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

HH
Henry H. Ji Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chairman, President & Ceo

HJ
Henry Ji Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Executive Officer

SS
Scott Schaus Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Technology Officer

NA
No Agent ACTIVE

Residence
🇺🇸 United States
Occupation
Agent

EC
Elizabeth Czerepak ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Financial Officer

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

SORRENTO THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 17 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 17 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Four of the 17 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.

Ultimate HQ
SORRENTO THERAPEUTICS, INC.
United States
Scintilla Pharmaceuticals, Inc.
United StatesUS TX 5757137

Tnk Therapeutics, Inc.+ subsidiaries
United StatesUS CA 5717686

Levena San Diego Corp.
United StatesUS CA 6198665

Virex Health, LLC
United StatesUS MA 6402332

Sherrington Pharmaceuticals, Inc.
United StatesUS NY 4648344

Igdrasol, Inc.
United StatesUS CA 5156318

Smartpharm Therapeutics, Inc.
United StatesUS MA 6614156

Acea Therapeutics, Inc.+ subsidiaries
United StatesUS CA 6492627

+9 more entities

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on SORRENTO THERAPEUTICS, INC.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns SORRENTO THERAPEUTICS, INC.?

Three shareholders are currently on record for SORRENTO THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is BlackRock Funds V-BlackRock High Yield Portfolio, holding 97.1% — a majority holding — followed by BlackRock Funds V-BlackRock Income Fund at 1.5%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is SORRENTO THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for SORRENTO THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does SORRENTO THERAPEUTICS, INC. have on record?

3 shareholders are shown on record for SORRENTO THERAPEUTICS, INC..

What is SORRENTO THERAPEUTICS, INC.'s company registration number?

SORRENTO THERAPEUTICS, INC.'s registration number is 3263030, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.

Is SORRENTO THERAPEUTICS, INC. still an active company?

SORRENTO THERAPEUTICS, INC.'s status on California Secretary of State — bizfile Online is listed as active.

When was SORRENTO THERAPEUTICS, INC. incorporated?

SORRENTO THERAPEUTICS, INC. was incorporated on 7 December 2009, according to California Secretary of State — bizfile Online.

What is SORRENTO THERAPEUTICS, INC.'s registered address?

The registered address on file for SORRENTO THERAPEUTICS, INC. is SAN DIEGO, United States.

Who are the officers/directors of SORRENTO THERAPEUTICS, INC.?

The Chairman, President & Ceo of SORRENTO THERAPEUTICS, INC. currently on record is Henry H. Ji Ph.d.; five officers are currently on record for SORRENTO THERAPEUTICS, INC., filed with California Secretary of State — bizfile Online. Management authority at SORRENTO THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does SORRENTO THERAPEUTICS, INC. have a parent company or subsidiaries?

SORRENTO THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 17 subsidiaries recorded beneath it across 1 jurisdiction. Those 17 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Four of the 17 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.

Can Zavia monitor changes to SORRENTO THERAPEUTICS, INC.'s ownership over time?

This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to SORRENTO THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access SORRENTO THERAPEUTICS, INC.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like SORRENTO THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 4 October 2026.

This website uses cookies to improve your web experience.